Execute 30-35% tranched trim of MDLZ; Underweight rating maintained on confirmed structural deterioration despite intact $58.48 structural floor
Execute a 30-35% tranched trim of MDLZ over 1-2 weeks as the disciplined synthesis between the Aggressive analyst's structural bear case and the Conservative/Neutral analysts' defensive floor argument. Underweight rating is correct given: (1) gross margin collapsed from 39.1% to 28.4% (1,070bps) with Q1 2026 at 27.8%—a regime change not yet reflected in 18.57x forward P/E; (2) FCF coverage compression to 1.30x with $974M working capital headwind risking sub-1.0x coverage; (3) three confirming deterioration signals (MACD bearish cross Sept 4, zero Q1'26 buybacks, Net Debt/EBITDA expansion to ~3.8x). Underweight rather than full Sell because: (1) 200 SMA at $58.48 has held for 42+ sessions and is rising $0.50-1.00/month; (2) brand portfolio (Oreo, Cadbury, Toblerone, Milka, Clif) provides irreplaceable franchise floor; (3) fair value is $50-55 (13-20% downside), not the Aggressive analyst's $40-43; (4) 3.37% dividend yield with 7.8% growth CAGR provides income buffer. Reject trader's full Sell at $63 with stop at $65.50—$65.50 stop is 0.68 ATR and gets whipsawed by normal volatility; revised stop at $66.50 (~3.7 ATR from $61.63) is wide enough to absorb noise. Reject XLP-long/MDLZ-short pair: correlation risk in defensive rotation makes it a leveraged directional bet with a correlation mask.
| Position | Action |
|---|---|
| Current levels ($61.50-$62.00) | Trim ~one-third of position |
| Retest of $63.50-$64.70 resistance zone (failed breakout/50 SMA/Bollinger midline confluence) | Trim ~one-third of position |
| Confirmed close below $60.64 (lower Bollinger) on volume ≥8M | Trim remaining ~one-third as contingent trigger |
| Residual position after trim | Hard stop at $57.50 (below 200 SMA at $58.48) |
| Target benchmark weight | No more than 60-65% of benchmark weight |
MDLZ is a quality compounder at a cyclical trough with exceptional brands (Oreo, Cadbury, Milka, Toblerone), stable cash flow ($3.0–$3.6B FCF), and compelling valuation (18.57x forward P/E, 0.91 PEG) positioned to mean-revert when cocoa prices normalize.
| Indicator | Value | Signal |
|---|---|---|
| close_200_sma | 58.48 | bullish |
| close_50_sma | 61.53 | neutral |
| close_10_ema | 62.09 | bearish |
| macd | -0.08 | bearish |
| macds (Signal) | +0.21 | bearish |
| macdh (Histogram) | -0.29 | bearish |
| rsi | 46.11 | neutral |
| boll (Middle Band) | 62.73 | neutral |
| boll_ub (Upper Band) | 64.83 | neutral |
| boll_lb (Lower Band) | 60.64 | bullish |
| atr |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price retests $63.50-$64.70 zone (failed breakout/50 SMA/Bollinger midline confluence)
Then: Execute ~one-third trim
↩ rebuts: “Bear's concerns about competitive positioning”
EV: +5.4% above 200 SMA at $58.48; upside to $66+ mentioned · concedes: Oil at $101 is a real cost headwind; Fed holding at 93% no-cut odds is real; Deutsche Bank bearish on European staples; Sugar/oil cost channel is a temporary input cost issue, not structural margin reset; Poland shrinkflation scrutiny acknowledged
MDLZ is a defensive compounder running at structurally compressed margins (27-28% vs. historical 38-39%), propped up by stretched working capital and supplier credit, facing multi-year input cost pressure, structural demand threats from GLP-1 adoption and private label, and sitting on its last major technical support — making this a regime change, not a cyclical trough.
· concedes: The bull is correct that Q2 2025 gross margin of 32.7% shows the company CAN recover margins if input costs normalize; West African cocoa supply impairment is not guaranteed to persist forever — there is some probability of normalization over a longer time horizon; The dividend hike does temporarily signal management confidence, even if it may be masking capital discipline stress; Q1 2026 net income of $560M is technically an improvement over Q1 2025's $402M; Some technical support exists at $60-61 — a bounce is possible even if the underlying trend is bearish; The $58.48 200 SMA has not yet been broken — it remains intact as a support level
→ vs neutral: HOLD stance described as 'analysis paralysis'; 50-day MA at 61.54 and stock already closed at 61.63; waiting for pullback is irrelevant as the pullback is already happening while fundamentals deteriorate, not improve
→ vs conservative: Waiting for confirmation at 50 SMA (61.53) risks turning a 15% drawdown into 30%; if price bounces 1.5% before resuming downtrend, entry is missed; MACD signal already bearish and stop at 65.50 is only 6% above current price with asymmetric risk favoring selling now
→ vs conservative: Dividend at 3.37% described as defensive floor is actually a 'delayed detonator'; FCF coverage at 1.30x with FCF compressed from 3.6B to 3.24B; if working capital headwind of 974M repeats, FCF drops to 2.3-2.4B and coverage goes below 1.0x, causing income holders to sell
→ vs conservative: Assumes gross margins will recover, but Q1 2026 confirms 27.8% gross margin; recovery is not in the prints and cocoa has been elevated for 18 months, sugar is rising, Europe is weak as durable not transitory conditions
→ vs neutral: Sentiment score of 6.2 called 'laughable'; 6 of 7 articles dismissed as PR noise not earnings drivers; Cramer dividend signal read as operational deterioration mask, not quality signal; Reddit silence confirms fast money has left
| 1.33 |
| neutral |
| vwma_30 | 62.69 | bearish |
| close | 61.63 | neutral |
| volume | 10.08M | bearish |
Support: 61.53 · 60.64 · 58.48 | Resistance: 62.09 · 62.73 · 64.83
MDLZ technical analysis shows a mixed picture with bearish short-term momentum but intact long-term uptrend. The MACD bearishly crossed below its signal line on 2026-09-04 with histogram now expanding negative at -0.29. Price is below the 10 EMA (62.09) and VWMA (62.69), sitting on 50 SMA support at 61.53 with the Bollinger lower band at 60.64 as the next support test. RSI neutral at 46.11 indicates no overbought/oversold extremes. Resistance sits at 62.09 (10 EMA), 62.73 (Bollinger middle), and 64.83 (Bollinger upper). Long-term trend remains bullish above 200 SMA at 58.48. Stance is HOLD — wait for either a close above 62.09 with MACD histogram turn or a test of 60.60 with bullish reversal candles before initiating new positions.
Market Cap
$79.67B
P/E (TTM)
22.86
Forward P/E
18.57
PEG Ratio
0.91
P/B
3.00
EPS (TTM)
$2.73
Forward EPS
$3.36
Dividend Yield
3.37%
Beta
0.40
52-Week High
$66.65
52-Week Low
$51.20
50-Day Avg
$61.54
200-Day Avg
$59.13
Revenue (FY2025)
$38.54B
Revenue (FY2024)
$36.44B
Revenue (FY2023)
$36.02B
Revenue (FY2022)
$31.50B
Revenue (FY2021)
$28.72B
Gross Profit (FY2025)
$10.94B
Gross Profit (FY2024)
$14.26B
Gross Margin (FY2025)
28.4%
Gross Margin (FY2024)
39.1%
Gross Margin (FY2023)
38.2%
Operating Income (FY2025)
$3.62B
Operating Income (FY2024)
$6.67B
Operating Margin (FY2025)
9.4%
Operating Margin (FY2024)
18.3%
EBITDA (FY2025)
$4.97B
EBITDA (FY2024)
$8.07B
EBITDA Margin (FY2025)
12.9%
EBITDA Margin (FY2024)
22.1%
Net Income (FY2025)
$2.45B
Net Income (FY2024)
$4.61B
Net Income (FY2023)
$4.96B
Diluted EPS (FY2025)
$1.89
Diluted EPS (FY2024)
$3.42
Diluted EPS (FY2023)
$3.62
Net Margin (FY2025)
6.4%
Net Margin (FY2024)
12.7%
ROE (TTM)
13.3%
ROA (TTM)
4.1%
Total Assets (FY2025)
$71.49B
Total Debt (FY2025)
$21.80B
Net Debt (FY2025)
$19.08B
Stockholders' Equity (FY2025)
$25.84B
Debt/Equity
0.84x
Current Ratio (FY2025)
0.60
Working Capital (FY2025)
($8.91B)
Tangible Book Value (FY2025)
($18.13B)
Goodwill & Intangibles (FY2025)
$43.96B
Operating Cash Flow (FY2025)
$4.51B
Free Cash Flow (FY2025)
$3.24B
CapEx (FY2025)
$1.28B
Dividends Paid (FY2025)
$2.49B
Buybacks (FY2025)
$2.39B
Total Capital Return (FY2025)
$4.87B
FCF Dividend Coverage
1.30x
Revenue CAGR (FY21-25)
~7.6%
Dividend CAGR (FY22-25)
~7.9%
Impairment Charges (FY2025)
$85M
Strengths
Concerns
Mondelez International is a global snack and confectionery giant with ~$79.67B market cap, operating iconic brands (Oreo, Cadbury, Toblerone, Milka) across 80+ countries. The company is currently experiencing a severe earnings trough in FY2025 with gross margins compressing ~1,070 bps to 28.4% due to unprecedented cocoa and commodity cost inflation, driving net income down ~50% from peak. However, the cash flow engine remains remarkably resilient with operating cash flow stable at $4.51B and free cash flow at $3.24B, supporting a well-covered 3.37% dividend and aggressive $4.87B capital return to shareholders in FY2025. The investment thesis hinges on whether FY2026 quarters show margin stabilization/recovery toward historical 15-18% operating margins, which would drive significant EPS expansion given the stock trades at a forward P/E of 18.57x with PEG of 0.91 — representing an asymmetric recovery opportunity if input costs normalize.
Macro: Hawkish macro pivot driving negative sentiment: Fed-cut probability collapsed to 7% for 2026 (93% odds of no cuts, up 4pp in one week); WTI crude at $101/barrel on Middle East tensions; sugar futures rising via ethanol substitution; 10-year yields rising on Treasury buyback plan; USD firmer on no-cuts regime creating EM/AMEE revenue translation headwind; US recession odds at 8%; Deutsche Bank bearish on European staples sector.